Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 03, 2023, titled "Zydus and Lupin sign licensing agreement for co-marketing of Saroglitazar Mg, a critical treatment for chronic liver diseases in India".
Press Release Nov 03 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Nov 02 2023
- Press Release Oct 31 2023
- Press Release Oct 30 2023
- Press Release Oct 25 2023
- Press Release Oct 20 2023
Later from Zydus Lifesciences
- Zydus Lifesciences Limited Press Release Nov 06 2023
- Press Release Nov 07 2023
- Press Release Nov 10 2023
- Press Release Dec 01 2023
- Zydus Lifesciences Limited Press Release Dec 06 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences